49.52
price down icon0.94%   -0.47
after-market 시간 외 거래: 50.31 0.79 +1.60%
loading
전일 마감가:
$49.99
열려 있는:
$50.14
하루 거래량:
2.80M
Relative Volume:
0.89
시가총액:
$121.57B
수익:
$43.23B
순이익/손실:
$6.79B
주가수익비율:
12.36
EPS:
4.0051
순현금흐름:
$9.17B
1주 성능:
-1.00%
1개월 성능:
+5.63%
6개월 성능:
-6.60%
1년 성능:
-6.37%
1일 변동 폭
Value
$49.43
$50.41
1주일 범위
Value
$49.43
$50.72
52주 변동 폭
Value
$44.62
$60.12

사노피 ADR Stock (SNY) Company Profile

Name
명칭
Sanofi Adr
Name
전화
-
Name
주소
-
Name
직원
82,878
Name
트위터
@sanofi
Name
다음 수익 날짜
2024-10-25
Name
최신 SEC 제출 서류
Name
SNY's Discussions on Twitter

SNY을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - General icon
SNY
Sanofi Adr
49.52 120.97B 43.23B 6.79B 9.17B 4.0051
Drug Manufacturers - General icon
LLY
Lilly Eli Co
821.04 716.78B 53.26B 13.80B -50.20M 15.08
Drug Manufacturers - General icon
JNJ
Johnson Johnson
192.47 462.11B 92.15B 25.12B 18.18B 10.36
Drug Manufacturers - General icon
ABBV
Abbvie Inc
228.25 408.76B 58.33B 3.73B 18.24B 2.1013
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
131.64 254.25B 53.40B 13.68B 16.89B 6.8864
Drug Manufacturers - General icon
MRK
Merck Co Inc
87.18 218.86B 63.43B 16.42B 14.72B 6.4861

사노피 ADR Stock (SNY) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-09-08 업그레이드 Morgan Stanley Equal-Weight → Overweight
2025-09-02 업그레이드 Deutsche Bank Hold → Buy
2025-08-08 업그레이드 JP Morgan Neutral → Overweight
2025-04-15 개시 Exane BNP Paribas Outperform
2025-03-21 개시 Goldman Neutral
2025-01-30 업그레이드 Deutsche Bank Sell → Hold
2024-07-26 재확인 Argus Buy
2024-01-23 개시 Morgan Stanley Equal-Weight
2024-01-16 재개 UBS Buy
2023-12-05 다운그레이드 JP Morgan Overweight → Neutral
2023-10-30 다운그레이드 Stifel Buy → Hold
2023-09-06 업그레이드 Berenberg Hold → Buy
2023-07-14 개시 HSBC Securities Buy
2023-04-28 다운그레이드 Deutsche Bank Hold → Sell
2023-03-27 업그레이드 Barclays Equal Weight → Overweight
2022-12-13 재개 Morgan Stanley Overweight
2022-08-12 업그레이드 Deutsche Bank Sell → Hold
2022-08-09 다운그레이드 UBS Buy → Neutral
2022-05-23 개시 SVB Leerink Outperform
2021-09-27 업그레이드 SVB Leerink Mkt Perform → Outperform
2021-01-15 개시 Deutsche Bank Sell
2020-09-29 개시 Berenberg Hold
2020-03-17 업그레이드 Barclays Underweight → Equal Weight
2020-03-11 업그레이드 Goldman Neutral → Buy
2020-02-11 개시 SVB Leerink Mkt Perform
2020-01-06 업그레이드 JP Morgan Neutral → Overweight
2019-09-23 업그레이드 Guggenheim Neutral → Buy
2019-09-20 업그레이드 Morgan Stanley Equal-Weight → Overweight
2019-09-03 개시 Bernstein Outperform
2019-08-14 업그레이드 UBS Neutral → Buy
2018-12-11 업그레이드 Jefferies Hold → Buy
2018-11-01 업그레이드 Barclays Underweight → Equal Weight
2018-10-09 개시 Guggenheim Neutral
2018-09-10 업그레이드 BofA/Merrill Neutral → Buy
2018-08-10 업그레이드 Citigroup Neutral → Buy
2018-03-23 업그레이드 Liberum Hold → Buy
2018-01-23 다운그레이드 Barclays Equal Weight → Underweight
2017-12-06 다운그레이드 BofA/Merrill Buy → Neutral
2017-12-01 다운그레이드 Morgan Stanley Overweight → Underweight
2017-11-15 업그레이드 Barclays Underweight → Equal Weight
2017-08-30 업그레이드 HSBC Securities Reduce → Hold
모두보기

사노피 ADR 주식(SNY)의 최신 뉴스

pulisher
01:00 AM

Hidradenitis Suppurativa Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 24+ Companies and 26+ Therapies | DelveInsight - GlobeNewswire Inc.

01:00 AM
pulisher
Oct 17, 2025

Sanofi's Rezurock Approval Stumbles In EU For Chronic Graft-Vs-Host Disease - Sahm

Oct 17, 2025
pulisher
Oct 17, 2025

FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times - Sahm

Oct 17, 2025
pulisher
Oct 16, 2025

Sanofi’s AlphaMedix Achieves Key Efficacy Endpoints in Phase 2 Study - The Globe and Mail

Oct 16, 2025
pulisher
Oct 16, 2025

Sanofi (SNYNF) Gets a Buy from J.P. Morgan - The Globe and Mail

Oct 16, 2025
pulisher
Oct 11, 2025

SanofiAmerican Depositary Shares (NQ: SNY - FinancialContent

Oct 11, 2025
pulisher
Oct 04, 2025

UBS Reaffirms Their Buy Rating on Sanofi (SNYNF) - The Globe and Mail

Oct 04, 2025
pulisher
Oct 02, 2025

Leerink Partners Sticks to Its Buy Rating for Sanofi (SNYNF) - The Globe and Mail

Oct 02, 2025
pulisher
Sep 29, 2025

BostInno🗳️ Vote in Inno Madness round two | 💻 UKG announces layoffs - The Business Journals

Sep 29, 2025
pulisher
Sep 26, 2025

Sanofi Expands Insulin Savings Program To Cover All US Patients - Sahm

Sep 26, 2025
pulisher
Sep 26, 2025

Amgen Expands US Manufacturing Network Amid New Tariff Policy - Sahm

Sep 26, 2025
pulisher
Sep 17, 2025

Sanofi Reports Early Brivekimig Data, Signals Strong Efficacy And Good Tolerability - Sahm

Sep 17, 2025
pulisher
Sep 16, 2025

AstraZeneca Puts Cambridge Expansion On Ice Adding Pressure On Starmer Ahead Of Trump Visit - Sahm

Sep 16, 2025
pulisher
Sep 12, 2025

Sanofi: Informations relatives au nombre de droits de vote et d'actions - GlobeNewswire Inc.

Sep 12, 2025
pulisher
Sep 10, 2025

Mandy Moore and Celebrity Mom Squad join Sanofi to help protect babies from RSV with BEYFORTUS® - Ariva

Sep 10, 2025
pulisher
Sep 05, 2025

Leerink Partners Sticks to Their Buy Rating for Sanofi (SNY) - The Globe and Mail

Sep 05, 2025
pulisher
Sep 04, 2025

What's Going On With Nektar Therapeutics Stock On Thursday? - Sahm

Sep 04, 2025
pulisher
Sep 04, 2025

Why Is Sanofi Stock Falling Thursday? - Sahm

Sep 04, 2025
pulisher
Sep 04, 2025

Sanofi Hit With Shock As Flagship Drug Successor Disappoints Investors - Sahm

Sep 04, 2025
pulisher
Aug 26, 2025

New Report Highlights Community Health Workers' Impact, Calls for Sustained Local Investment, During National CHW Awareness Week - Ariva

Aug 26, 2025
pulisher
Aug 21, 2025

European ADRs Under Pressure: Sector Divergence and Strategic Entry Points - AInvest

Aug 21, 2025
pulisher
Aug 06, 2025

Novavax Ups Outlook, Eyes Stronger Nuvaxovid Sales - Sahm

Aug 06, 2025
pulisher
Aug 05, 2025

Dupixent Leads the Charge for Sanofi's Strong Portfolio in Immunology, Vaccines, and Rare Diseases - Morningstar

Aug 05, 2025
pulisher
Aug 05, 2025

Janus Henderson Global Life Sciences Diversified ADR Managed Account Q2 2025 Commentary - Seeking Alpha

Aug 05, 2025
pulisher
Aug 01, 2025

Novo Nordisk's Alhemo Wins FDA Nod, Expanding Subcutaneous Option For Hemophilia Patients - Sahm

Aug 01, 2025
pulisher
Jul 31, 2025

Sanofi ADR (SNY) Stock: A Year of Stock Market Ups and Downs - investchronicle.com

Jul 31, 2025
pulisher
Jul 31, 2025

Sanofi ADR earnings beat by $0.63, revenue fell short of estimates - Investing.com Nigeria

Jul 31, 2025

사노피 ADR (SNY) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
drug_manufacturers_general PFE
$24.67
price down icon 0.20%
$120.74
price down icon 0.59%
$292.89
price down icon 1.04%
drug_manufacturers_general NVO
$53.23
price down icon 0.28%
drug_manufacturers_general MRK
$87.18
price down icon 0.49%
자본화:     |  볼륨(24시간):